Epidermolysis bullosa acquisita: Diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin

Clinical and Experimental Dermatology

Volumn 31, Issue 1, 2006, Pages 71-73

  Campos, M ^a   Silvente, C ^a   Lecona, Manuel ^a   Suarez R ^a   Lazaro P ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ARTICLE; BASEMENT MEMBRANE; CASE REPORT; DRUG ADMINISTRATION; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ANTIBODIES; BASEMENT MEMBRANE; DRUG ADMINISTRATION SCHEDULE; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33646082519     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01989.x     Document Type: Article

References (9)

1. De Jong MC, Bruins S, Heeres K et al. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol 1996; 132: 151-7.
2. Kazama T, Yamamoto Y, Hashimoto T, Komai A, Ito M. Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. Br J Dermatol 1998; 138: 593-601.
3. Wozniak K, Kazama T, Kowalewski C. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003; 139: 1007-11.
4. Ahmed AR, Dahl MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Der-matol 2003; 139: 1051-9.
5. Hallel-Halevy D, Nadelman C, Chen M, Woodley DT. Epidermolysis bullosa acquisita: update and review. Clin Dermatol 2001; 19: 712-18.
6. Engineer L, Ahmed AR. Emerging treatment for epidermo-lysis bullosa adquisita. J Am Acad Dermatol 2001; 44: 818-28.
7. Mutasim DF. Management of autoimmune bullous diseases: Pharmacology and therapeutics. J Am Acad Dermatol 2004; 51: 859-77.
8. Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 2002; 138: 380-4.
9. Jolles S. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol 2001; 26: 127-31.